UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
GATX Corp
GATX
$6.38B
| $1.67M | ﹤0.01% |
31,442
+2,200
| +8% | +$125K |
|
1427
DNOW Inc
DNOW
$2.88B
| $1.67M | ﹤0.01% |
83,766
+4,900
| +6% | +$112K |
|
1428
Rithm Capital
RITM
$5.6B
| $1.67M | ﹤0.01% |
109,410
+46,775
| +75% | +$776K |
|
|
TIME
1429
DELISTED
Time Inc.
TIME
| $1.67M | ﹤0.01% |
72,404
-275,993
| -79% | -$6.3M |
|
1430
Synaptics
SYNA
$4.08B
| $1.67M | ﹤0.01% |
19,199
+3,600
| +23% | +$329K |
|
1431
OneMain Financial
OMF
$7.52B
| $1.66M | ﹤0.01% |
36,115
+23,015
| +176% | +$1.12M |
|
1432
Molina Healthcare
MOH
$10.1B
| $1.65M | ﹤0.01% |
23,515
+7,516
| +47% | +$503K |
|
|
HT
1433
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.64M | ﹤0.01% |
64,046
+2,625
| +4% | +$68K |
|
|
MSCC
1434
DELISTED
Microsemi Corp
MSCC
| $1.63M | ﹤0.01% |
46,497
+5,400
| +13% | +$190K |
|
|
CLDT
1435
Chatham Lodging
CLDT
$618M
| $1.62M | ﹤0.01% |
61,150
+4,055
| +7% | +$114K |
|
|
USG
1436
DELISTED
Usg
USG
| $1.62M | ﹤0.01% |
58,197
+4,700
| +9% | +$129K |
|
1437
Fair Isaac
FICO
$22.4B
| $1.62M | ﹤0.01% |
17,800
-100
| -0.6% | -$8.97K |
|
1438
Minerals Technologies
MTX
$2.4B
| $1.61M | ﹤0.01% |
23,699
+2,200
| +10% | +$153K |
|
1439
Novavax
NVAX
$1.28B
| $1.61M | ﹤0.01% |
7,235
+855
| +13% | +$150K |
|
1440
Western Alliance Bancorporation
WAL
$8.99B
| $1.6M | ﹤0.01% |
47,297
+3,700
| +8% | +$118K |
|
|
CSR
1441
Centerspace
CSR
$936M
| $1.59M | ﹤0.01% |
22,223
+3,531
| +19% | +$256K |
|
|
MDSO
1442
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.59M | ﹤0.01% |
29,198
+9,600
| +49% | +$515K |
|
|
SHLD
1443
DELISTED
Sears Holding Corporation
SHLD
| $1.58M | ﹤0.01% |
59,096
-3,674
| -6% | -$142K |
|
|
VCO
1444
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
| $1.57M | ﹤0.01% |
44,750
| – | – |
|
1445
MarketAxess Holdings
MKTX
$5.72B
| $1.56M | ﹤0.01% |
16,799
+2,200
| +15% | +$194K |
|
1446
Zurn Elkay Water Solutions
ZWS
$8.8B
| $1.56M | ﹤0.01% |
135,077
+28,441
| +27% | +$357K |
|
1447
Silgan Holdings
SLGN
$4.44B
| $1.55M | ﹤0.01% |
58,792
+5,400
| +10% | +$150K |
|
1448
Vanguard FTSE All-World ex-US ETF
VEU
$68.1B
| $1.54M | ﹤0.01% |
31,808
-5,614
| -15% | -$285K |
|
1449
Compañía de Cervecerías Unidas
CCU
$2.21B
| $1.54M | ﹤0.01% |
72,800
-27,300
| -27% | -$600K |
|
1450
Steven Madden
SHOO
$3.62B
| $1.54M | ﹤0.01% |
54,072
+4,050
| +8% | +$107K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.